These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 230784)

  • 1. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Antimicrob Agents Chemother; 1979 May; 15(5):723-9. PubMed ID: 230784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Antimicrob Agents Chemother; 1979 Sep; 16(3):266-70. PubMed ID: 507784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
    Klein RJ; Friedman-Kien AE; Yellin PB
    Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.
    Klein RJ; Friedman-Kien AE; Brady E
    Arch Virol; 1978; 57(2):161-6. PubMed ID: 208489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice.
    Field HJ; Bell SE; Elion GB; Nash AA; Wildy P
    Antimicrob Agents Chemother; 1979 Apr; 15(4):554-61. PubMed ID: 464587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Infect Immun; 1981 Dec; 34(3):693-701. PubMed ID: 6277789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.
    Klein RJ; Friedman-Kien AE; Fondak AA; Buimovici-Klein E
    Infect Immun; 1977 Jun; 16(3):842-8. PubMed ID: 197008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on the acute local phase of herpes simplex virus-induced skin infections in mice and the establishment of latency.
    Klein RJ; Friedman-Kien AE
    Antimicrob Agents Chemother; 1985 May; 27(5):763-8. PubMed ID: 3874596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
    Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B; Vahlne A; Lycke E
    Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain.
    Klein RJ; Kaley LA; Friedman-Kien AE
    Vaccine; 1984 Sep; 2(3):219-23. PubMed ID: 6099650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma.
    Shimizu F; Monma Y; Sekizawa T; Kamiyama K
    J Dent Res; 1989 Mar; 68(3):472-5. PubMed ID: 2537858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.
    Price RW; Walz MA; Wohlenberg C; Notkins AL
    Science; 1975 May; 188(4191):938-40. PubMed ID: 166432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.
    Zweerink HJ; Martinez D; Lynch RJ; Stanton LW
    Infect Immun; 1981 Jan; 31(1):267-75. PubMed ID: 6260662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.
    Wohlenberg CR; Walz MA; Notkins AL
    Infect Immun; 1976 May; 13(5):1519-21. PubMed ID: 178609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.
    Klein RJ; Buimovici-Klein E; Moser H; Moucha R; Hilfenhaus J
    Arch Virol; 1981; 68(2):73-80. PubMed ID: 6264897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread.
    McKendall RR; Klassen T; Baringer JR
    Infect Immun; 1979 Feb; 23(2):305-11. PubMed ID: 217828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus.
    Yamamoto M; Hayashi Y; Tang LL; Mori R
    Antiviral Res; 1985 Apr; 5(2):83-91. PubMed ID: 2990334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.